Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, alcohol abstinence, antineoplastic, ADHD symptoms, anticancer, hypercholesterolemia, antimuscarinic, antimigraine, and thrombocytopenia. It also provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, atorvastatin calcium, azithromycin dihydrate, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, clopidogrel hydrochloride, dapoxetine hydrochloride, donepezil hydrochloride, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nateglinide, nitazoxanide, nitrosamine, pazopanib hydrochloride, quetiapine hemifumarate, raltegravir potassium, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide, as well as contract research and manufacturing services. The company exports its products. Ind-Swift Laboratories Limited was incorporated in 1995 and is based in Manimajra, India.
Low
87.15
High
424.75
Low
379.50
High
409.90
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How Ind-Swift Laboratories Limited stacks up against its Drug Manufacturers - Specialty & Generic peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | INDSWFTLAB Ind-Swift Laboratories Limited | 394.00 | 1.35% | 57.95 | 6.80 | 3,436 | 20.82% | 306.19% | 424.75 / 87.15 |
| 2 | AARTIDRUGS Aarti Drugs Limited | 419.00 | 2.76% | 20.01 | 20.94 | 3,824 | 0.95% | 10.78% | 534.00 / 318.95 |
| 3 | AARTIPHARM Aarti Pharmalabs Limited | 980.00 | 2.75% | 44.50 | 22.02 | 8,854 | 16.11% | 15.70% | 1,002.40 / 585.00 |
| 4 | ABBOTINDIA Abbott India Limited | 26,850.00 | 1.01% | 35.33 | 759.88 | 57,033 | 1.13% | 15.17% | 30,655.00 / 25,135.00 |
| 5 | AHCL ANLON HEALTHCARE LIMITED | 32.86 | 4.97% | 13.55 | 2.42 | 1,746 | 112.69% | 261.10% | 37.24 / 10.37 |
| 6 | AJANTPHARM Ajanta Pharma Limited | 3,586.00 | 0.96% | 39.48 | 90.83 | 44,748 | 0.17% | 43.15% | 3,796.00 / 2,379.30 |
| 7 | AKUMS AKUMS DRUGS AND PHARMA L | 815.80 | 0.33% | 42.83 | 19.05 | 12,490 | 5.06% | 78.90% | 838.80 / 409.30 |
| 8 | ALIVUS Alivus Life Sciences Limited | 1,380.00 | 0.05% | 28.15 | 49.03 | 16,942 | 0.80% | 47.27% | 1,493.80 / 819.00 |
| 9 | ALKEM Alkem Laboratories Limited | 5,215.00 | 1.00% | 28.90 | 180.45 | 62,353 | 3.03% | 1.79% | 5,933.50 / 5,051.00 |
| 10 | AMRUTANJAN Amrutanjan Health Care Limited | 516.00 | 0.24% | 27.63 | 18.67 | 1,483 | 1.70% | 25.36% | 760.15 / 476.50 |
| 11 | APLLTD Alembic Pharmaceuticals Limited | 819.00 | 0.78% | 23.22 | 35.27 | 16,099 | 0.26% | 12.03% | 998.00 / 635.80 |
| 12 | ASTRAZEN AstraZeneca Pharma India Limited | 6,010.00 | 2.85% | 88.58 | 67.85 | 15,078 | 17.26% | 28.96% | 9,849.50 / 5,986.00 |
| 13 | AUROPHARMA Aurobindo Pharma Limited | 1,666.30 | 0.34% | 26.03 | 64.00 | 96,479 | 3.88% | 62.92% | 1,740.00 / 1,066.80 |